INDmoney
Fredun Pharma Share Price
₹1690.95
+113.35
(+7.18%)
as on
Fredun Pharma Stock Performance
as on March 10, 2026 at 9:31 pm IST
Day's Low
Day's High
₹1,600.00₹1,840.00
5.38%
Downside
8.81%
Upside
52 Week's Low
52 Week's High
₹635.05₹1,999.0062.44%
Downside
18.22%
Upside
Fredun Pharma share price movements today
- Previous Close
- ₹1,577.60
- Open
- ₹1,643.00
- Volume
- 13.71K
- Upper Circuit
- ₹1,893.10
- Lower Circuit
- ₹1,262.10
- Day's Low - High
- ₹1,600.00 - ₹1,840.00
- 52 Week Low - High
- ₹635.05 - ₹1,999.00
Fredun Pharma Historical Returns
- 1 Month Return
- -11.51 %
- 3 Month Return
- -7.69 %
- 1 Year Return
- + 132.17 %
- 3 Year Return
- + 77.11 %
- 5 Year Return
- + 211.47 %
Fredun Pharma Fundamentals
as on March 10, 2026 at 4:01 pm IST
Market Cap
₹846.54 Cr
Return on Equity (ROE)
14.34
PE Ratio (TTM)
22.79
Return on capital employed (ROCE)
16.95
Industry PE ratio
42.02
Beta (LTM)
0.7
P/B Ratio
2.81
Dividend Yield
0PEG Ratio
0.57
Quarterly Earnings Growth YOY
-23.73
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Fredun Pharma Stock Valuation
as on March 10, 2026 at 4:01 pm IST
Fredun Pharma in the last 5 years
Lowest (0.00x)
March 28, 2025
Today (22.79x)
March 9, 2026
Industry (42.02x)
March 9, 2026
Highest (27.20x)
February 11, 2026
Today’s Price to Earnings Ratio: 22.79x
Fredun Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Fredun Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 846.54 | 42.29% | 0.00 | 15 | 348 | |
| NA | 2,481.09 | 3.75% | 0.68 | 3 | 2,711 | |
| NA | 59.84 | -8.37% | 0.00 | 4 | 61 | |
| BUY | 27,637.89 | -6.53% | 0.53 | 698 | 5,616 | |
| NA | 32.35 | 0.64% | 0.63 | 5 | 96 |
Fredun Pharma Stock’s Investor Sentiment and Interest
Search interest for Fredun Pharmaceuticals Ltd Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:15% versus previous 30 day period
Fredun Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Fredun Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Fredun Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Fredun Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Fredun Pharma .
Fredun Pharmaceuticals Ltd Earnings Results
Fredun Pharmaceuticals Ltd’s net profit fell -23.73% since last year same period to ₹10.48Cr in the Q3 2025-2026. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 11.13% jump in its net profits since last 3-months.
Read More about Earnings ResultsFredun Pharmaceuticals Ltd Dividends May,2025
In the quarter ending March 2025, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 per share on 31 May 2025 - translating a dividend yield of 0.04%.
Read More about Dividends
Insights on Fredun Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, Fredun Pharma stock has moved up by 26.0%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, Fredun Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.46% to 1.06% in Feb 2026 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 189.4% return, outperforming this stock by 112.2%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 43.06% of holdings in Feb 2026 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 53.00% to 52.99% in Feb 2026 quarter
About Fredun Pharmaceuticals Ltd
Consequently, FPL was approved to be listed on the stock exchange in April 1996, and decided to use the funding for international expansion, repaying term loans, and reducing interest burden. Furthermore, FPL is continually registering its products across various countries with the hopes of increasing its overall turnover and boosting export orders. Currently, FPL is successfully registering drugs in countries such as Nepal, Tanzania, Uganda, and Sri Lanka.
Revenue: ₹159.93Cr as on December 2025 (Q3 FY26)
Net Profit: ₹10.48Cr as on December 2025 (Q3 FY26)
Chairperson Name: Daulat N Medhora
| Organisation | Fredun Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Daulat N Medhora |
| E-voting on shares | Click here to vote |
FAQs
What is Fredun Pharma share price today?
Fredun Pharma share price today stands at ₹1690.95 as on at the close of the market. Fredun Pharma share today touched a day high of ₹1840 and a low of ₹1600.
What is the 52 week high and 52 week low range for Fredun Pharma share?
Fredun Pharma touched a 52 week high of ₹1999 and a 52 week low of ₹635.05. Fredun Pharma share price today i.e. is closed at ₹1690.95, which is -15.41% down from its 52 week high and 166.27% up from its 52 week low.
What is Fredun Pharma 's market capitalisation today?
Fredun Pharma market capitalisation is ₹846.54 Cr as on .
How to buy Fredun Pharma shares?
To buy Fredun Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 539730 or Fredun Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Fredun Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Fredun Pharma trading volume today?
Fredun Pharma trading volume is 13.71K as on . This means that 13.71K shares of Fredun Pharma were bought and sold on the stock market during today's trading session.